Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.55 -0.71 (-6.31%)
As of: Oct 2, 2026 · 1:58 PM EDT

Monte Rosa Therapeutics (GLUE) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) recorded Net Equity Issued and Repurchased of $2.6 million in Q2 2026, down 42.5% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

On a TTM basis, Monte Rosa Therapeutics' Net Equity Issued and Repurchased came in at $12.83 million as of Jun 30, 2026; for FY2025, it came in at $5.72 million, down 88.6% from FY2024.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $50 million in FY2024 (+100.0%), $25 million in FY2023 (+24.7%), $20.06 million in FY2022 (-91.6%) and $237.75 million in FY2021 (+293.0%).
  • Quarterly Net Equity Issued and Repurchased has ranged from $14,000 in Q1 2025 to $49.75 million in Q2 2024 over the past five years.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 834.4% in Q2 2023, against a decline of 99.9% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.52 million (Q1 2026), $5.36 million (Q4 2025) and $348,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Monte Rosa Therapeutics 1.02 Bn 428.56 Mn - 2.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.60 Mn
Mar 31, 2026 4.52 Mn
Dec 31, 2025 5.36 Mn
Sep 30, 2025 348,000.00
Mar 31, 2025 14,000.00
Jun 30, 2024 49.75 Mn
Mar 31, 2024 246,000.00
Dec 31, 2023 22.98 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 897,000.00
Mar 31, 2023 18,000.00
Dec 31, 2022 6.55 Mn
Sep 30, 2022 13.26 Mn
Jun 30, 2022 96,000.00
Mar 31, 2022 153,000.00
Sep 30, 2021 31.01 Mn
Jun 30, 2021 63.74 Mn
Mar 31, 2021 143.00 Mn
Sep 30, 2020 48.00 Mn
API Access

Monte Rosa Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GLUE&period=max&api_key=YOUR_API_KEY